|
|
Volumn 19, Issue 12, 2004, Pages
|
|
Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment
|
|
Author keywords
Chronic hepatitis C virus; Combination treatment; Peginterferon alfa 2a; Thymalfasin
|
|
Indexed keywords
INTERFERON;
PEGINTERFERON ALPHA2A;
RIBAVIRIN;
THYMOSIN ALPHA1;
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ANTIVIRUS AGENT;
MACROGOL DERIVATIVE;
RECOMBINANT PROTEIN;
THYMOSIN;
VIRUS RNA;
ADULT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DOSE RESPONSE;
DRUG DOSE REGIMEN;
FEMALE;
HEPATITIS C;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
MALE;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PILOT STUDY;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT OUTCOME;
UNITED STATES;
ANALOGS AND DERIVATIVES;
BLOOD;
DRUG COMBINATION;
DRUG EFFECTS;
GENETICS;
GROWTH, DEVELOPMENT AND AGING;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
METHODOLOGY;
MIDDLE AGED;
PHASE 3 CLINICAL TRIAL (TOPIC);
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT FAILURE;
VIRUS LOAD;
VIRUS REPLICATION;
ADULT;
ANTIVIRAL AGENTS;
CLINICAL TRIALS, PHASE III AS TOPIC;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
POLYETHYLENE GLYCOLS;
RECOMBINANT PROTEINS;
RESEARCH DESIGN;
RNA, VIRAL;
THYMOSIN;
TIME FACTORS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
UNITED STATES;
VIRAL LOAD;
VIRUS REPLICATION;
ADJUVANTS, IMMUNOLOGIC;
INTERFERON ALFA-2A;
|
|
EID: 11144220015
PISSN: 08159319
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1400-1746.2004.03632.x Document Type: Conference Paper |
|
Times cited : (14)
|
|
References (4)
|
